AOU Policlinico G. Rodolico
Catania, Italy, 95124
NCT Number: NCT06028867
Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCT study is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Catania, Italy, 95124
Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCTstudy is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis. The study was designed as a double-blind randomized controlled trial (RCT) with three parallel groups of individuals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subgingival biofilm ultrasonic debridement
Time frame: 2 weeks
Subgingival biofilm collected with sterile paper strips and analyzed by polimerase chain reaction
University of Catania
Other
Validation of the Clinical and Antimicrobial Effectiveness of a Clorexidine and Sodium DNA Based Mouthwash in Patients With Stage III and IV Periodontitis: a Randomized-controlled Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07751393
Gingival Diseases, Gingivitis
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07751419
Gingival Diseases, Gingivitis
Malatya, Turkey (Türkiye)
View Trial DetailsNCT03671408
CRP, Heart Transplant Failure
View Trial DetailsNCT07731412
Body Weight, Mouth Diseases
Târgu Mureş, Romania
View Trial Details